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A criterion frequently used to group chemicals in risk assessment is “mode of
toxic action” (MoA). Routinely, structure-based approaches are used for the MoA
categorization of chemicals, but they can produce conflicting results or fail to classify
compounds. Biological activity-based approaches such as toxicogenomics which
provide an unbiased overview of the transcriptomic changes after exposure to a
compound may complement structure-based approaches in MoA assignment. Here,
we investigate whether toxicogenomic profiles as generated after in vitro exposure of
an established cell line (C3A hepatoma cells) are able to group together chemicals
with an uncoupling MoA, and to distinguish the uncouplers from chemicals with other
MoAs. In a first step, we examined whether chemicals sharing the same uncoupling
of oxidative phosphorylation (OXPHOS) MoA produce similar toxicogenomic profiles
and can be grouped together. In a next step, we tested whether the toxicogenomic
profiles discriminate between OXPHOS and chemicals displaying a (polar) narcotic MoA.
Experimentally, cells were exposed in vitro to equipotent concentrations of the test
compounds and gene expression profiles were measured. The resulting toxicogenomic
profiles assigned OXPHOS to one cluster and discriminated between the OXPHOS and
the (polar) narcotics. In addition, the toxicogenomics data revealed that one and the
same chemical can display multiple MoAs, which may help to explain conflicting results
of MoA classification from structure-based approaches. The results strongly suggest the
feasibility of MoA grouping of chemicals by using in vitro cell assay-based toxicogenomic
profiles.
Keywords: OXPHOS, in vitro, toxicogenomics, microarray, mode of action, uncoupler, chemical risk assessment
INTRODUCTION
Chemical risk assessment has to deal with a large and ever growing number of chemical substances.
At the same time, increasing regulatory demands that are designed to ensure the health and safety
of both humans and ecosystems lead to increasing needs for chemical toxicity testing. In this
situation, a compound-by-compound evaluation using traditional toxicity testing approaches is
hardly feasible given the resources needed in terms of time, labor, and costs, and with respect to
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ethical considerations, as it would necessitate the use of extensive
numbers of experimental animals. Thus, toxicologists are faced
with the challenge to develop novel approaches of chemical
hazard assessment which reduce testing needs and animal usage
while still generating robust safety data (Mantus, 2007; NRC,
2007; ECHA, 2011; Kavlock et al., 2012).
One possibility to increase efficiency of chemical hazard
assessment is to categorize chemicals. In such a group-wise
evaluation the unknown toxicity of untested compounds can
be inferred from the known toxicity of tested compounds. A
criterion that is frequently used to group chemicals is their “mode
of toxic action” (MoA). MoA is a loosely defined term used in
both human toxicology and ecotoxicology, In this article, MoA
is referred to as key toxic processes (e.g., chemical binding to a
nuclear receptor) (Escher and Hermens, 2002; Vonk et al., 2009;
Carmichael et al., 2011; Kienzler et al., 2017). The question is
how to recognize that two chemicals have a common MoA, and
therefore can be grouped together? One possibility is to assign
MoA based on molecular interactions between the chemical and
the biological system which initiate specific toxicity pathways
like binding to the estrogen receptors, or measuring specific
cellular reactions that are indicative for specific effects such as
chlorophyll interference in tests with algae (Hamadeh et al., 2002;
Escher et al., 2005; Nendza andWenzel, 2006; Woods et al., 2007;
Pereira-Fernandes et al., 2014). Another approach is the grouping
of chemicals on the basis of structural rules (Schüürmann,
1998; Verhaar et al., 2000; Enoch et al., 2008; Blackburn et al.,
2011). The chemical similarity principle postulates that chemicals
with similar structure are likely to be toxicologically similar
because they act through similar MOAs (Martin et al., 2002;
Enoch et al., 2008). As recently reviewed by Kienzler et al.
(2017), various structure-based classification schemes have been
developed to group chemicals according to theirMoAs, including
the Verhaar scheme which classifies chemicals on the basis of
correlations between apical toxic endpoints such as lethality
and chemical descriptors like octanol-water partition coefficient
(kow) (Verhaar et al., 1992), or the ASTER scheme of the US EPA
which utilizes, among others, fish behavioral responses for MoA
classification (Barron et al., 2015). The results of the different
existing classifications schemes may differ. For instance, when
comparing the outcome of three MoA classification schemes
for 3,448 chemicals, Kienzler et al. (2017) found that only 432
out of the 3,448 chemicals were classified by all three schemes,
and only for 42% of these 432 chemicals, the three schemes
produced concordant MoA classifications. This illustrates that
the structure-based approaches for MoA classification, although
being highly useful, also have inherent limitations. Therefore, it
has been suggested to extend the structure-based approaches to
biological descriptors (Richard, 2006).
The present study examines the potential of toxicogenomic
information to augment MoA assignment. Toxicogenomics
has been selected as an experimental approach as it enables
unbiased, global profiling of the molecular biological response
space (Richard, 2006; Edwards and Preston, 2008), without pre-
selection of response parameters. For single chemicals, it has been
shown that exposure results in chemical-specific, gene expression
profiles (Hamadeh et al., 2002; Yang et al., 2007; Kiyosawa et al.,
2010; Janssens et al., 2011; Piña and Barata, 2011; Meganathan
et al., 2012; Theunissen et al., 2012). The hypothesis tested in
the present study is whether specific MoAs have common gene
expression profiles that can be used to classify compounds and
whether compounds with multiple MoAs can be classified and
distinguished from those with only one MoA. As the MoA to be
tested in the present study, we selected uncoupling of oxidative
phosphorylation (OXPHOS). The biological mechanism of
uncouplers is relatively well understood (Terada, 1990; Spycher
et al., 2005): they act as protonophores, which dissipate the
pH gradient across the proton-impermeable energy-transducing
membranes of mitochondria. As a consequence, phosphorylation
is uncoupled from the electron transport and from hydrogen
transfer. Uncoupling is normally assessed monitoring changes
in respiration rate or membrane potential of extracted liver
mitochondria or cells (Brand and Nicholls, 2011). Here, we
test a number of chemicals which have been classified as
uncouplers on the basis of biological mechanistic studies and/or
chemical descriptors, and evaluate how similar or dissimilar
their toxicogenomic profiles are, and whether these profiles
can be discriminated from profiles of chemicals with other
MoAs. In order to comply with the aim of reducing animal
experimentation in toxicity testing (Pereira-Fernandes et al.,
2014), we performed the toxicogenomic studies in an in-vitro test
system, the human liver HepG2/C3A cell line.
MATERIALS AND METHODS
Chemicals
All solvents were of pro analysis (p.a.) quality or better, and
purchased from Dr Grogg Chemie AG (Stettlen-Deisswil,
Switzerland) unless stated otherwise. Aniline (99%, CAS 62-
53-3, Product 132934), Benzo(a)pyrene (BaP) (≥ 96%, CAS
50-32-8, Product B1760), 4-Chloroaniline (Cl-aniline) (98%,
CAS 106-47-8, Product C22415), Dimethyl sulfoxid (DMSO)
(99.5%, CAS 67-68-5, Product D4540), Ethylenglycol (1,2-
Ethanediol, analytical standard, CAS 107-21-1, Product
85978), Pentachlorophenol (PCP) (98%, CAS 71-23-8,
Product 402893), 2,3,4,5-Tetrachlorophenol (TCP) (99.9%,
CAS 4901-51-3, Product 442281), were purchased from
SIGMA-ALDRICH (Buchs, Switzerland). Carbonyl cyanide 3-
chlorophenylhydrazone (CCCP) (99+%, CAS 555-60-2, Product
L06932) was purchased from Alfa Aesar (Karlsruhe, Germany).
Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone
(FCCP) (>99%, CAS 370-86-5, Product 0453) was purchased
from TOCRIS (Missouri, USA). 6OH-BDE90 was synthesized
in the Department of Materials and Environmental Chemistry,
Environmental Chemistry Unit, Stockholm University, Sweden
(Marsh et al., 1999, 2003). If needed, stock solutions and
dilutions of the test substances were prepared in DMSO as
vehicle solvent and were added to the culture to give a final
DMSO concentration of 0.1% at maximum.
Cell Culture Maintenance
C3A hepatoma cells were obtained from LGC Standards
(HepG2/C3A, Hepatocellular Carcinoma, Human (Homo
sapiens), ATCC-CRL-10741, Middlesex, UK). C3A is a clonal
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TABLE 1 | Uncoupler of the oxidative phosphorylation candidate compound list.
Name CAS Paper
1-Naphthol 90-15-3 Ru
2,3,4,5-tetrachlorophenol 4901-51-3 S G
2,3,4,5-Tetrachlorophenol 4901-51-3 Ru
2,3,4,6-tetrachlorophenol 58-90-2 S Ru
2,3,5,6-tetrachlorophenol 935-95-5 G
2,3,5,6-Tetrafluorophenol 769-39-1 G
2,3-dinitrophenol 66-56-8 G
2,4,5-trichlorophenol 95-95-4 S
2,4,6-tribromophenol 118-79-6 S
2,4,6-Trichlorophenol 88-06-2 S
2,4,6-trinitrophenol 88-89-1 S G
2,4-dichloro-6-nitrophenol 609-89-2 G
2,4-dichlorophenol 120-83-2 S
2,4-dinitrophenol 51-28-5 S G Ru
2,5-dinitrophenol 329-71-5 G
2,6-dibromo-4-nitrophenol 99-28-5 S G
2,6-dichloro-4-nitrophenol 618-80-4 G
2,6-dichlorophenol 87-65-0 Ru
2,6-diiodo-4-nitrophenol 305-85-1 G
2,6-dinitro-4-cresol 609-93-8 G
2,6-dinitrophenol 573-56-8 S G Ru
2-sec-butyl-4,6-dinitrophenol 88-85-7 S Ru
2-tert-butyl-4,6-dinitrophenol 1420-07-1 S
3,4,5,6-tetrabrom-2-cresol 576-55-6 G
3,4,5-Trichlorophenol 609-19-8 S
3,4-dichlorophenol 95-77-2 S
3,4-dinitrophenol 577-71-9 S G
3,5-dibromo-4-hydroxy-benzonitrile 1689-84-5 S
3,5-dibromo-4-methylphenol 13979-81-2 S
3,5-dichloro-4-hydroxybenzonitril 1891-95-8 Ru
3,5-dichlorophenol 591-35-5 S
3,5-diiodo-4-hydroxybenzonitril 1689-83-4 Ru
3-chloro-N-[3-chloro-2,6-dinitro-4
(trifluoromethyl) phenyl]-5-
(trifluoromethyl)-2-Pyridinamin
79622-59-6 S
3-Trifluoromethyl-4-nitrophenol 88-30-2 Ru
4,5,6,7-tetrabromo-2-
(trifluoromethyl)-benzimidazol
2338-30-9 S
4,5,6,7-tetrachloro-2-(trifluoromethyl)-
benzimidazol
2338-29-6 S
4,6-dinitro-2-cresol
(4,6-dinitro-o-cresol)
534-52-1 G
4,6-dinitro-o-cresol 534-52-1 S G Ru
4-methyl-2,6-dinitrophenol 609-93-8 S
4-Nitro-2-
trifluoromethylbenzimidazole
14689-51-1 S
4-Nitrobenzamide 619-80-7 Ru
4-Nitrophenol 100-02-7 S
4-tert-butyl-2,6-dinitrophenol 4097-49-8 S
5,6-dichloro-2-(pentafluoroethyl)-
benzimidazol
102516-93-
8
S
5,6-dichloro-2-(trifluoromethyl)-
benzimidazol
2338-25-2 S
5-chloro-2-(2,4-dichlorophenoxy)-
phenol
3380-34-5 S
5-nitro-2-trifluoromethylbenzimidazole 327-19-5 S
(Continued)
TABLE 1 | Continued
Name CAS Paper
6-Chloro-2,4-dinitrophenol 946-31-6 S
Carbonyl_cyanide_m-
chlorophenylhydrazone
555-60-2 S
Carbonyl-cyanide-p-
methoxyphenylhydrazone
370-86-5 S
Pentabromophenol 608-71-9 G
Pentachlorophenol 87-86-5 S G Ru
Pentachloropyridine 2176-62-7 Ru
Pentafluorophenol 771-61-9 G
p-phenylazophenol 1689-82-3 Ru
Each compound is a designated uncoupler of the oxidative phosphorylation based
on structural alerts. The column “paper” refers to the corresponding published paper
(Russom et al., 1997; Schüürmann et al., 2003; Spycher et al., 2008b).
derivative of the HepG2 cell line. Cells were cultured in 75-cm2
vent cell culture flasks (TPP+, Trasadingen, Switzerland) in
Minimal Essential Medium with phenol red indicator (MEM,
Gibco, Product 31095, Zug, Switzerland) adding 10% FCS (Fetal
Calf Serum, Gibco, Product 10290, Zug, Switzerland), 1% NEAA
(MEM Non-Essential Amino Acids, Gibco, Product 11140-035,
Zug, Switzerland), 1mM Sodium Pyruvat (Sigma-Aldrich, CAS
113-24-6, Product P5280, Buchs, Switzerland), and 1% Penicilin-
Streptomycin (Penn-Strep) (Sigma-Aldrich, Product P4333,
Buchs, Switzerland). Incubation temperature was set at 37◦C.
Cells were subcultivated (split 1:2) twice weekly. The subculture
procedure is described elsewhere (Marsh et al., 1999, 2003;
Whitmore et al., 2000). 0.05% trypsin-EDTA was used to detach
cells from the flask (Trypsin, Gibco, Product 15400-054, Zug,
Switzerland).
For toxicity testing, C3A cells were grown in 75 cm2 culture
flasks until ∼80% confluency. Cells were then subcultured as
quoted above until the uptake of trypsinised cells in media. C3A
cells were diluted to reach a final density of 250 000 cells/ml.
Two hundred microliters of cell suspension were seeded in the
inner 60 wells of a black 96-well plate with clear bottom (Greiner
bio-one, Product 655906, Reinach, Switzerland). The outer rows
were filled with 200 µl 1x PBS (phosphate buffered saline,
Sigma-Aldrich, Buchs, Switzerland). Cells were pre-incubated at
37◦C for 24 h. After pre-incubation cells were treated with the
test chemicals. Therefore, the test substances were dissolved in
DMSO and added to culture medium at a final concentration
of 0.1% DMSO to reach the desired test concentration in the
test-medium.
Tetramethylrhodaminemethylester
(TMRM)-Assay
Tetramethylrhodaminemethylester (TMRM) is a positively
charged dye, exhibiting a red color. In cells with intact membrane
potential, TMRM accumulates in the active mitochondria, due
to their relative negative charge. When the membrane potential
collapses, TMRM is no longer retained in the mitochondria
and the observed fluorescence decreases. Culture medium
was aspirated from the cells and 200µl exposure medium
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TABLE 2 | Compounds tested in the different bioassyas (TMRM, TPP+ and Cytotoxicity), abiological proven uncoupler, bQSAR designated uncoupler.
Compound MoA logKOW TMRM assay EC50 inµM TPP
+ assay LOEC inµM Cytotoxicity EC50 inµM
CCCP Uncouplera,b 3.4 5.5 0.01 63.5
FCCP Uncouplera,b 3.7 1.2 0.5 26.9
TCP Uncouplera,b 4.45 9.3 0.5 25.7
PCP Uncouplera,b/narcotic 5.1 117.8 0.5 224.8
6OH-BDE90 Suspected uncoupler 6.8 n.t. 1.3 3.5
Ethylenglycol Polar narcotic −1.36 – – 220
Cl-aniline Narcotic 1.83 amb – 9,100
AnilineAniline Narcotic 0.95 amb – 25,800
BaP Receptor mediated n.t. n.t. n.t.
n.t., not tested; amb., ambiguous results; –, no effects.
were gently added. After 2 h incubation, exposure medium
was aspirated and TMRM medium was gently added to
the wells. The TMRM medium was prepared by adding
TMRM [Tetramethylrhodaminemethylester (perchlorate),
99%, CAS 115532-50-8, Product 88065, Anawa, Zürich,
Switzerland] at a final concentration of 125 nM to serum-
and phenol red-free culture medium (MEM without phenol
red, Product 51200, Gibco, Zug, Switzerland). The cells were
incubated in TRMR medium for 20min. Afterwards, TMRM
medium was aspirated, and 100µl of phenol red free medium
was added. Fluorescence was measured instantly using the
EnSpire R© microplate reader (Perkin Elmer, Schwerzenbach,
Switzerland) at 540 nm excitation wavelength and 575 nm
emission. Solvent controls (0.1% DMSO), positive controls
(2.5µM FCCP) and medium controls were included
in all experiments. Per test concentration six well were
measured and each experiment was repeated at least three
times.
Triphenylphosophonium (TPP+) Assay
The TTP+ assay is measuring changes in the inner
mitochondrial membrane potential (19) and mitochondrial
respiration (O2) in isolated rat liver mitochondrial with help
of tetraphenylphosphonium (TPP+) and oxygen sensitive
electrodes. The amount of free TPP+ in the reaction medium
is a relative measurement of 19 . The experimental animals
were sacrificed according to ethical procedures and the rat livers
were immediately collected and kept in cold 0.9% NaCl(aq).
The tissue was homogenized in isolation medium (0.25M
sucrose, 10mM HEPES, 3mM EGTA, 0.2% BSA) and then
centrifuged for 6min at 3,000 rpm 750 g at 4◦C (one liver in
50ml isolation medium). The supernatant was transferred
to a clean tube and was centrifuged for 10min at 10,000 g.
Supernatant was removed, and the pellet washed with wash
medium (0.25M sucrose, 5mM HEPES, 0.1% BSA) and
centrifuged for 10min at 10,000 g. The pellet was resuspended in
a small volume of wash medium. For simultaneous measurement
of respiration and inner mitochondrial membrane potential
(19), the mitochondria were incubated at 25◦C in reaction
medium (85mM KCl, 20mM HEPES, 5 mN KH2PO4, 2.3mM
MGCl2, 25mM creatine, 25mM phosphocreatine) in a closed
and stirred perspex vessel equipped with an oxygen electrode
and a TPP+-sensitive electrode (Kamo et al., 1979). Coupling
between respiration (O2), inner membrane potential (1ψ)
and ATP (Adenosine triphosphate) production in the isolated
mitochondria was demonstrated by addition of succinate
(1mM) and ATP (10mM) to initiate oxidative phosphorylation.
Rotenone was also added to block complex I (NADH-UQ
reductase) of the electron transport chain (ETC), which
allowed us to study inhibitory effects on the ETC as well as
protonophoric uncoupling. All test compounds (dissolved
in DMSO) were injected into the vessel after the membrane
potential was stable (i.e., when state 4-respiration had been
reached). For each compound, different concentrations were
tested. Due to the complexity of the test n = 1 for the LOEC
determination.
Cytotoxicity assay
The cytotoxic action of the test compounds on C3A cells
was measured using the resaruzine dye which assesses cell
viability. Therefore, the amount of resazurine (non-toxic,
non-fluorescent redox active blue dye) that is reduced to
resorufin (non-toxic, highly fluorescent, pink dye) by metabolic
activity in the cells was measured fluorometrically (Abu-
Amero and Bosley, 2005). Therefore, culture medium was
aspirated from the cells and 200µl exposure medium was
gently added. Total volume reached 200µl. After 22 h of
exposure, 10µl of 440µM resazurine (resazurine sodium
salt, CAS 62758-13-8, Product R7017, Sigma-Aldrich, Buchs,
Switzerland) was added to the wells. Fluorescence (excitation
wavelength 530 nm and emission wavelength at 590 nm) was
measured immediately (T0) using EnSpire R© microplate reader.
After 2 h, fluorescence was measured again (T2). Background
fluorescence was subtracted by applying the equation T2h-
T0h for each well. Exposure was carried out in six replicates
per concentration. Finally, the T2h-T0h fluorescence of each
replicate was averaged and the standard deviation calculated.
Solvent control (0.1% DMSO) and positive control (0.03%
H2O2), as well as a negative control (medium) were incorporated
in all experiments. Per test concentration six well were
measured and each experiment was repeated at least three
times.
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FIGURE 1 | Chemical structures of all the compounds studied.
Microarray Experiment
C3A cells were exposed for 2 h to substances as described above
for the TMRM assay. For microarray analysis, six replicate wells
per concentration were pooled. DMSO (0.1%) was used as solvent
control. The concentrations used for the exposure were:
Microarray 1: calculated EC50 values from the 2 h TMRM
assays, BaP 10µM.
Microarray 2: calculated EC25 values from the 24 h
cytotoxicity assays, i.e., CCCP: 22.8µM; FCCP 15.7µM;
TCP: 13.8µM; PCP: 101.7µM; 6OH-BDE90: 4.2µM;
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FIGURE 2 | Dose-response curves for single compounds in the TPP+ assay.
Measurement of respiration rate (V) vs. mitochondria membrane potential
(MMP) (Left). Each point represents the measurements after compound was
added to the vessel. After addition of compound the membrane potential
decreases (non-disrupted MMP ∼180mv) and the oxygen consumption
increases (uncoupling). At higher concentrations, the oxygen consumption
starts to decrease indicating inhibition. Measurement of respiration rate (V) vs.
concentration of compound (Right). After addition of compound the oxygen
consumption increases (uncoupling). At higher concentrations, the oxygen
consumption starts to decrease indicating inhibition.
FIGURE 3 | Dose-response curves for single compounds in the cytotoxicity
assay (Left) and the TMRM assay (Right). For each experiment six wells per
test concentration were averaged and each experiment was repeated three
times. Data points present the mean over all measurements and the bars the
standard deviation. TMRM graphs for Aniline and Cl-aniline where ambiguous,
instead of a decrease an increase of the TMRM signal could be observed.
6OH-BDE90 was not measured in the TMRM assay.
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Aniline: 44.66mM; Cl-aniline: 6.54mM; Ethylenglycol:
558.8mM.
Total RNA was extracted using RNeasy Mini Kit (QUIAGEN,
Product 74104, Hombrechtikon, Switzerland) according to
manufacturers’ instructions. DNA was digested using the
RNeasy Mini Kit optional on-column DNase digestion. Quality
of extracted RNA was checked via the Nanodrop 1000
spectraphotomoeter V3.7, as well as running the samples on a
1.5% agarose gel.
Total RNA was reverse transcribed to cDNA using 1µg RNA
Template. The reaction mix per sample had a total volume
of 25µl. The reaction mix contained the following products
purchased from Promega AG (product number in brackets)
(Promega AG, Dübendorf, Switzerland): 0.5µl RNasin R© Plus
RNAse Inhibitor (N2611), 1.25µl 10mM dNTP (U1201, U1211,
U1221, U1231), 1µl M-MLV Reverse transcriptase (RNase H
Minus, Point Mutant) (M3682), 5µl of 5x Buffer (M3682), 1µl
random primer (C1181), Xµl DEPC-water to reach the final
volume of 25µl. After reverse transcription, samples were diluted
10x to prevent inhibition of the PCR reaction by the cDNA
synthesis buffer. The diluted cDNA was stored at −20◦C until
further usage.
For Microarray 1: Each treatment consisted of two biological
replicates, the control consisted of three biological replicates.
The RNA 6000 NanoChip kit (Agilent Technologies, number
506791511) was used with the Agilent 2100 Bioanalyzer
(Agilent technologies) for analysis of total RNA samples.
Samples with a RIN (RNA integrity number) above 7 were
considered appropriate for consequent microarray testing.
For Microarray analysis, Agilent SurePrint G3 Human Gene
TABLE 3 | Range of the test concentrations for Ethylenglycol, Cl-aniline, and
Aniline which did not induce any effects on the oxygen consumption or membrane
potential (data not shown).
Ethylenglycol tested from 6.3µM up to 260.5mM
Cl-aniline tested from 6.3µM up to 3.8mM
Aniline tested from 3.4mM up to 85mM.
FIGURE 4 | Hierarchical cluster analysis of C3A cells exposed to 3 compounds (FCCP, CCCP, and TCP) with a known uncoupling MoA and BaP). (A) The hierarchical
cluster analysis is based on the 5000 most varying genes. (B) The hierarchical cluster analysis is based on the significantly regulated genes (|M|> 1).
Expression Microarrays (8x60K) were used in combination with
a one-color based hybridization protocol (OneColor RNA Spike-
In Mix, Agilent Technologies, number 51885282). All steps
were carried out according to the manufacturer’s instructions.
Fluorescent signal intensities were detected with Scan Control
A.8.4.1 Software (Agilent Technologies) on the Agilent DNA
Microarray Scanner and extracted from the images using Feature
Extraction 10.7.3.1 Software (Agilent Technologies). A quality
check as described by the manufacturer was performed (e.g.,
SpikeIn controls).
For Microarray 2: In order to analyze more compounds
in a comparative way we changed that microarray approach
as following. Each treatment and controls consisted of three
biological replicates. The RNA 6000 NanoChip kit (Agilent
Technologies, number 506791511) was used with the Agilent
2100 Bioanalyzer for analysis of total RNA samples following
the manual instructions. Samples with a RIN (RNA integrity
number) above 7 were considered appropriate for consequent
microarray testing. For Microarray analysis Agilent SurePrint
G3 Human Gene Expression Microarrays (8x60K) were used
(GPL14550). All replicates of the treatments were labeled
with Cy5 and all corresponding solvent controls with Cy3.
After hybridization, the microarrays were washed using Gene
TABLE 4 | Correlation coefficient between treatments for microarray experiment 1.
BAP CCCP FCCP TCP
A
BAP 1.00 −0.13 −0.25 −0.14
CCCP −0.13 1.00 0.83 0.78
FCCP −0.25 0.83 1.00 0.72
TCP −0.14 0.78 0.72 1.00
B
BAP 1.00 −0.05 −0.07 0.07
CCCP −0.05 1.00 0.90 0.81
FCCP −0.07 0.90 1.00 0.75
TCP 0.07 0.81 0.75 1.00
(A) For the 5000 genes with the highest variation. (B) For the most regulated genes with
a fold change of >2 or <0.5 (|M|>1). Correlation coefficients above 0.7 are marked with
gray background.
Frontiers in Environmental Science | www.frontiersin.org 7 November 2017 | Volume 5 | Article 80
Hawliczek-Ignarski et al. MoA Assignment Using Toxicogenomics
FIGURE 5 | Principle component analysis (PCA) of the 1st microarray experiment (Left) and the 2nd microarray experiment (Right). Clear differences between
uncoupler and non-uncoupler can be observed.
FIGURE 6 | Venn diagram showing the overlap of genes that were regulated
with a fold change of >2 or <0.5 (|M|>1) between treatments of microarray
experiment 1. Only five genes overlap between all treatments.
ExpressionWash Buffer Kit (Agilent Technologies), and scanned
using the Scan Control Software A8.5 with the feature
extraction 10.X Software (Agilent technologies) on the DNA
microarray scanner G2505C (Agilent Technologies). More
detailed description of the design of the microarrays (platform)
is available from Gene Expression Omnibus (http://www.
ncbi.nlm.nih.gov/geo/) under accession number GPL13607. All
microarray data from this study have been deposited in
NCBI’s Gene Expression Omnibus under the accession number
GSE75784. A quality check as described by the manufacturer was
performed (e.g., SpikeIn controls).
Microarray Data Analysis
The microarray data was normalized, filtered, and biological
replicates averaged. The complete microarray analysis was done
using MatlabR2013a.
For the first microarray study a general quality check of the
raw array data was performed (spot integrity, signal distribution).
The data was normalized using quantile-normalization. Control
spots as well as not uniform spots were removed. The solvent
control was averaged and the M value (log2FoldChange)
calculated. Duplicated spots on the array were averaged before
exposure replicates were averaged using the median. This data
set was used for further analysis as described in the results.
For the second microarray study a general quality check
of the raw data was performed. M values (log2FoldChange)
were calculated and LOEWESS and centering normalization
applied. Non-uniform and control spots were removed from
the data set before duplicated spots on the array were averaged
(Median). Then exposure replicates were averaged using median.
To identify significantly regulated genes, genes expressed |M|>2
were selected and a t-test performed. Adjusted p-values were
calculated using the Bonferroni-Hochberg correction and a
cut-off of 0.1 applied. The Pearson correlation coefficient
between normalized and averaged replicates was calculated using
MaltlabR2013a.
Data Analysis (Cytotoxicity and TMRM)
For the TMRM assay as well as for the cytotoxicity assay, the
fluorescence was assessed as described above and dose-response
curves were fitted using GraphPad Prism 5 (GraphPad Software
Inc., Ca, USA). For dose-response curves, a sigmoidal curve with
the formula Y=A+ (D-A/(x/EC50)∧b) was used, where A is
the minimum effect, D is the maximum effect, x is the chemical
concentration, b is the slope was used. Confidence intervals were
set at 95%. This formula was used to calculate the EC25 and
EC50. Significant differences in response were calculated using
the T-test in GraphPad. P-Values were ≤ 0.05.
RESULTS AND DISCUSSION
The aim of the present study was to explore the suitability of an
in vitro-based toxicogenomic approach for MoA assignment of
chemicals. The MoA under consideration in the present study
was uncoupling of OXPHOS. It is known that uncoupling can
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FIGURE 7 | Hierarchical cluster analysis of C3A cells exposed to seven compounds (Ethylenglycol, Cl-aniline, Aniline, PCP, CCCP, FCCP, and TCP). (A) The
hierarchical cluster analysis is based on the 5000 most varying genes. (B) The hierarchical cluster analysis is based on the significantly regulated genes (|M|>2 and
padj <0.1).
FIGURE 8 | Venn diagram showing the overlap of genes from the core
uncoupler set that were regulated in both microarray experiments.
lead to fast transcriptional changes related to the physiological
remodeling due to the disruption of ATP generation (Hänninen
et al., 2010), and this mechanism may be reflected in the gene
signatures of the uncoupler-exposed C3A cells.
Selection of Chemicals with Uncoupling
MoA
The selection of chemicals with uncoupling MoA for the
experiments of the present study was carried out on the one
hand on the basis of biological mechanistic studies and, on the
other hand, on the basis of studies applying physico-chemical
descriptors. For FCCP and CCCP, several reports describe
an interference with proton transfer across the mitochondrial
membranes (LeBlanc, 1971; McLaughlin and Dilger, 1980;
Terada, 1981; Lim et al., 2001; Stöckl et al., 2007). Since also
studies using structural rules identified FCCP and CCCP as
uncouplers (Spycher et al., 2005, 2008a), these two compounds
were selected as positive controls. In addition, we compiled a
list of chemicals that were suggested to have an uncoupling
MoA on the basis of structural alerts and physico-chemical
descriptors (Schüürmann et al., 2003; Spycher et al., 2005,
2008a,b) which, however, were not proven to act as uncouplers
in biological uncoupling assays. From the candidate compounds
listed in Table 1, TCP and PCP were selected as compounds
with uncoupling MoA mainly based on structural rules. Studies
with black lipid bilayer also suggest uncoupling for PCP and
TCP (McLaughlin and Dilger, 1980) and experiments with
chromophores for TCP (Escher et al., 1996). Finally, chemicals
with MoA’s other than uncoupling were included as negative
controls: BaP as a chemical with a specific MoA (agonist
of the arylhydrocarbon receptor), Cl-aniline and aniline as
polar narcotics, and ethylenglycol as a narcotic or baseline
toxicant (Table 2). The structural information about the applied
compounds are shown in Figure 1.
Biological Assessment of the Uncoupling
Activity of the Test Compounds
Two different bioassays were applied to verify if the selected
compounds act as biological uncouplers. The hypothesis was
that FCCP, CCCP, TCP, and PCP should display protonophoric
activity, whereas no such activity should be observed for BaP,
the anilines and ethylenglycol. Two bioassays were used for
measuring the protonophoric activity: the TMRM assay which
is sensitive to alterations of membrane potential (Ehrenberg
et al., 1988) was applied to our test system, the mammalian
C3A cell line. Additionally, we performed the TPP+ assay which
is commonly used to test for uncoupling. The TPP+ assay
provides a direct measurement of mitochondrial respiration and
membrane potential in isolated rat mitochondria (Lichtshtein
et al., 1979). The results are shown inTable 2. Both assays showed
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TABLE 5 | Correlation coefficient between treatments for microarray experiment 2.
Ethylenglycol 6OH-BDE90 Cl-aniline Aniline CCCP PCP FCCP TCP
A
Ethylenglycol 1.00 0.40 0.21 0.40 0.25 0.08 0.21 0.27
6OH-BDE90 0.40 1.00 0.57 0.66 0.46 0.60 0.50 0.68
Cl-aniline 0.21 0.57 1.00 0.74 0.54 0.70 0.50 0.43
Aniline 0.40 0.66 0.74 1.00 0.40 0.53 0.39 0.41
CCCP 0.25 0.46 0.54 0.40 1.00 0.62 0.91 0.71
PCP 0.08 0.60 0.70 0.53 0.62 1.00 0.64 0.66
FCCP 0.21 0.50 0.50 0.39 0.91 0.64 1.00 0.75
TCP 0.27 0.68 0.43 0.41 0.71 0.66 0.75 1.00
B
Ethylenglycol 1.00 0.48 0.38 0.50 0.44 0.26 0.41 0.42
6OH-BDE90 0.48 1.00 0.71 0.72 0.63 0.74 0.67 0.76
Cl-aniline 0.38 0.71 1.00 0.83 0.66 0.77 0.63 0.59
Aniline 0.50 0.72 0.83 1.00 0.57 0.66 0.56 0.54
CCCP 0.44 0.63 0.66 0.57 1.00 0.71 0.94 0.81
PCP 0.26 0.74 0.77 0.66 0.71 1.00 0.72 0.75
FCCP 0.41 0.67 0.63 0.56 0.94 0.72 1.00 0.83
TCP 0.42 0.76 0.59 0.54 0.81 0.75 0.83 1.00
(A) For the 5000 genes with the highest variation. (B) For the most significantly regulated genes. Correlation coefficients above 0.7 are marked with gray background.
TABLE 6 | Number of genes that are significant gene regulation (|M|> 2 and
padj < 0.1) in microarray experiment 2.
Ethylenglycol 6OH-BDE90 Cl-aniline Aniline CCCP PCP FCCP TCP
1,861 1,725 412 2,189 688 1,691 514 206
that FCCP and TCP have uncoupling activity. CCCP was clearly
positive in the TMRM assay, while in the TPP+ assay, first a
decrease in oxygen consumption was observed then an increase
indicating inhibition of OXPHOS together with uncoupling. The
dose-response curves for the TPP+ assay are shown in Figure 2
and the curves for the TMRM assay in Figure 3.
In contrast, for PCP, the TPP+ assay indicated an uncoupling
activity at a very low concentration of 0.5µM, while the TMRM
only showed effects at 118µM with a higher variability between
replicates. On the basis of structural descriptors, PCP is classified
as uncoupler (Terada, 1981; McKim et al., 1987; Nendza and
Müller, 2001; Schüürmann et al., 2003; Spycher, 2005; Spycher
et al., 2005, 2008a). The differences of effect concentrations
between our assays agrees well with what has been observed
by Schüürmann et al. (1997) The authors identified uncoupling
by an excess toxicity above the baseline level using 10 different
biological test systems. None of the test systems was specific for
uncoupling. In this study PCP was not identified as uncoupler.
The authors hypothesized that the uncoupling activity of PCP
exists but does not yield substantial contributions to its total acute
toxicity as quantified by the biological test systems, shown in a
very high baseline toxicity. The high lipophilicity of PCP (log
Kow of 5.04) leads to relatively high doses and correspondingly
high narcotic-type membrane perturbations in the organisms,
so that the additional uncoupling activity may not lead to a
significant increase in overall toxicity. This means that although
chemical descriptors classify PCP as uncoupler, the biological
space only partly reflects this activity.
Surprisingly, the two anilines showed an ambiguous response
in the TMRMbioassay at very high concentrations (mM). Instead
of a decrease of the TMRM an increase of the signal could be
observed. This might be due to an interference of the TMRM-dye
and the compounds. The TPP+ is more specific for uncoupling
activity than the TMRM assay which just measures membrane
integrity. Anilines are known to disrupt membranes which might
also explain the response in the TMRM assay. Only the polar
narcotic compound, ethylenglycol, was clearly negative in both
assays. The concentration range tested for the anilines and
ethylenglycol are presented in Table 3.
MoA Specific Gene Expression Profile at
Effect Based Concentrations
A first and essential pre-requiste to enable comparison of
toxigenomic profiles across compound sis the use of equipotent
concentrations of the test chemicals. These concentrations
were selected in the preliminary experiments and used for
the following experiments. To test whether C3A cells display
a toxicogenomic profile that is common for exposure to
uncouplers. a proof of principle experiment was performed
with the positive control compounds—FCCP, CCCP, and TCP
and BaP as a non-uncoupling negative control. To ensure the
comparability of the gene expression profiles, the test compounds
were applied at equipotent concentrations (Shioda et al., 2006).
The chemicals FCCP, CCCP, and TCP were tested at their EC50
values in the TMRM assay, i.e., the concentration which inhibited
TMRM uptake by 50%. For BaP, the concentration of 10µM
was used which is high enough to induce a significant biological
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FIGURE 9 | Hierarchical cluster analysis of C3A cells exposed to eight
compounds including 6OH-BDE90 (Ethylenglycol, Cl-aniline, Aniline, PCP,
CCCP, FCCP, and TCP). (A) The hierarchical cluster analysis is based on the
significantly regulated genes (|M|>2 and padj < 0.1). (B) The hierarchical
cluster analysis is based on the 5000 most varying genes.
response of the BaP-specific MoA, i.e., cytochrome P4501A
induction via the AhR, while it is low enough to avoid cytotoxicity
(Hockley et al., 2009). The Cyp1a1 expression was the highest
for the BaP exposed cells with an M value of +3. The M value
equals the log2 fold change value. The gene expression profiles
induced by the four test compounds were evaluated by means
of hierarchical clustering. To this end, the 5000 genes with the
highest signal variation over the whole data set were selected
(Figure 4A). Each of the test chemicals displayed an individual
gene expression profile, CCCP, FCCP, and TCP clustered close
to each other, while the BaP profile was clearly separated. In
an alternative analysis of the array data, we selected those
genes that were regulated with a fold change of >2 or <0.5
(|M|> 1). Also with this analysis, a high degree of similarity of
gene expression was evident for the uncouplers (FCCP, CCCP,
and TCP) and a clear separation of the non-uncoupler, BaP
(Figure 4B). Again, it can be seen that CCCP and FCCP are
more closely related in comparison to TCP but all uncouplers are
more similar to each other than to BaP. To further demonstrate
the similarities between the uncouplers the correlation coefficient
between treatments is calculated. TCP, FCCP, and CCCP all
have a correlation coefficient above 0.7, whereas BaP only shows
a negative correlation with the other compounds below 0.25,
for the 500 most varying genes and the most regulated genes
(Table 4). The result of a PCA analysis are shown in Figure 5.
Also in the PCA a clear separation from the uncoupler and BaP
is observable. An overlap of expressed genes showed that only
five genes are regulated by all treatments. Whereas, 125 genes
are regulated by all of the uncouplers (Figure 6, Table S1). In
summary, the gene expression profiles induced by these three
compounds clustered closely together, and separated clearly from
the “non-uncoupling negative control,” BaP. Importantly, the
cluster analysis was not done using genes selected on the basis of
mechanistic knowledge, but it simply relied on those genes which
showed the strongest variation or regulation. It is not only that
similar genes are regulated by these substances, but a majority
of the genes is regulated in the same direction indicating the
existence of a MoA specific gene expression profile.
MoA Specific Gene Expression Profile at
Cytotoxic Based Concentrations
While the former experiment used two strongly contrasting
MoAs—uncoupling vs. AhR activation—in a next experiment we
asked if the toxicogenomic profiles of compounds with more
similar MoA can be distinguished. To this end, two aniline
compounds and PCP were included which are suggested to
have a polar narcotic MoA, as well as ethylenglycol, which has
a narcotic MoA. Structure-based MoA assignments generate
equivocal results concerning the separation between polar
narcosis and uncoupling (Schüürmann et al., 1996), with some
studies classifying the anilines and PCP as uncouplers, while
other studies classifying them as polar narcotics (Russom et al.,
1997; Schüürmann et al., 1997; Argese et al., 2001; Spycher et al.,
2008a; Janssens et al., 2011; Dom et al., 2012). Since these test
chemicals are not unequivocally classified as uncouplers, the
TMRM assay could not be used for the selection of equipotent
test concentrations. Therefore, a cytotoxicity test was applied
to derive EC25 equipotent concentrations (Figure 3). The initial
analysis of the gene expression data was conducted using the
5000 most varying genes. The clustering results are shown in
Figure 7A. Again, each of the compounds tested induced an
individual gene expression profile but additionally similarities
between the profiles existed. The most similar expression profiles
were shown by CCCP, TCP, and FCCP. Thus, for the uncoupler
set, the gene expression profiles confirmed the previous results
and indicate that these three compounds cluster together. When
comparing regulated genes of the uncoupler set between the first
and second microarray experiment, a clear overlap could be seen
(Figure 8). As expected, the higher concentrations of the second
microarray experiment (EC25 cytotoxicity) altered more genes
than the EC50 from the TMRM assay. TCP was applied in both
experiments at similar concentrations therefore there was also
a high overlap of altered genes. The heat map shows a clearly
separated cluster of aniline and Cl-aniline vs. the core uncoupler
cluster (CCCP, FCCP, and TCP). The third cluster exhibited
by cluster analysis was the narcotic compound, ethylenglycol.
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When focusing on the most significantly regulated genes, the
core uncoupler set clustered together (Figure 7B). Again, PCP
clustered together with the uncoupler set but is most distinct.
The second cluster can be observed for the narcotics (Aniline
and Cl-aniline) tested. The polar narcotic ethylenglycol is clearly
separated from the other cluster. The results of the hierarchical
clustering are also reflected in the correlation coefficient analysis
(Tables 5A,B). The core uncoupler all correlate with a coefficient
of above 0.7. The same holds for the anilines. Ethylenglycol
does not correlate with any other treatment. The PCA analysis
also shows that ethylenglycol is separated from the other
treatments (Figure 5B). The number of significantly differently
expressed genes for all treatments is shown in Table 6. Aniline,
Ethylenglycol and PCP changed the most genes whereas TCP
and Cl-aniline altered the least number of genes. This shows that
the grouping of compounds is not based on number of regulated
genes.
Toxiogenomic-Based MoA Assignment of a
Chemical with Unknown MoA
In order to test the discrimination power of the toxicogenomic
approach, we tested the brominated flame retardant metabolite
6OH-BDE90 for which structural criteria do not allow a MoA
assignment, but an uncoupling MoA is suspected on the basis of
bioassay data. 6OH-BDE90 clustered together with the narcotics,
when the 5000 most varying genes were used (Figure 9A). When
analyzed for significant gene regulation (|M|> 2 and padj < 0.1),
6OH-BDE90 clusters together with PCP forming a new cluster
group next to the polar narcotics (Figure 9B).
Other studies confirm the equivocal behavior of PCP and
6OH-BDE90. Tests conducted by Legradi et al. (2014) including
PCP, 6OH-BDE90, and FCCP show in regard to the TPP+ assay
which does not give a positive response for narcotic substances,
PCP and FCCP exhibit a similar LOEC whereas 6OH-BDE90 has
a much higher LOEC, presenting a similar potency of PCP and
FCCP and a much lower potency for 6OH-BDE90. This finding
is in line with our classification analysis based on the 5000 most
varied genes (Figure 9A).
However, when comparing the effects of the three substances
in the a TMRM assay, which also gives a positive response
for uncoupling and narcotic substances, 6OH-BDE90 and PCP
both alter the membrane potential in a similar concentration
range whereas FCCP proves to be highly more potent (Legradi
et al., 2014). In line with our classification analysis based on the
significantly regulated genes, where 6OH-BDE90 and PCP from
a new sub cluster together next to the polar narcotics (Figure 9B).
It appears that 6OH-BDE90 and PCP have the potential
for both uncoupling and polar narcosis, depending on test
conditions (concentration, duration) or test species (Sixt et al.,
1995; Schüürmann et al., 1997; Legradi et al., 2014). The
findings presented in this study suggest that the toxicogenomic
approach is able to elucidate differences in MoA. In the case that
compounds act via several highly similar MoA, toxicogenomics
can reveal this and assign a compound to more than one MoA.
Nevertheless, the array has the advantage to demonstrate in one
single assay the diverse activity potentials of a compound and
this information is a valuable complement to structure-based
classification schemes.
In chemical risk assessment, MoA information is critical for
proper hazard classification as compounds belonging to the
same MoA class should show similar toxicity (Verhaar et al.,
2000; Cronin and Livingstone, 2004; Nendza and Wenzel, 2006;
Vonk et al., 2009). To date, the assignment of a chemical to a
MoA is largely done on the basis of structural rules (Bradbury
and Lipnick, 1990; Russom et al., 1997; Schüürmann, 1998).
This study explored the potential of toxicogenomic profiles in
MoA grouping of chemicals. Classification of chemicals and
MoA identification was made purely with discriminative gene
expression profiles and without any mechanistic profiling like
pathway analysis. The results strongly suggest that transcript
profiling indeed is able to identify MoA of chemicals and
also is able to distinguish between MoA. Furthermore, as
chemicals typically display several MoA, depending on the
exposure concentration, duration, biological receptor etc., this
ambiguity are well revealed by the array data, since high content
methodologies such as toxicogenomics are appropriate tools to
deal with such multi-dimensional properties. The present study
exemplified this for the cases PCP and 6OH-BDE90 where
structural rules yield equivocal results. The applicability of our
approach for more MoA and larger chemical sets needs to be
further investigated. Proper selection of reference compounds is
essential and might be limited. Defining similarity and defining
groups might also be more complicated when more MoA are
included and advanced statistical analysis necessary. Exposure
time could also be adapted to get more specific profiles. For
certain MoA a treatment duration of 2 h might not be enough
to induce a discriminative profile whereas for other MoA a
longer exposure might be too long and mostly general stress
response effects visible. Nevertheless, our results indicate that
toxicgenomics profiling might be a useful approach for MoA
assessment of chemicals.
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